bricanyl turbuhaler inhalatsioonipulber
astrazeneca ab - terbutaliin - inhalatsioonipulber - 0,25mg 1annus 200annus 1tk
cordarone 50 mg/ml süste-/infusioonilahuse kontsentraat
sanofi-aventis estonia oÜ - amiodaroon - süste-/infusioonilahuse kontsentraat - 50mg 1ml 3ml 6tk
cordarone 200 mg tablett
sanofi winthrop industrie - amiodaroon - tablett - 200mg 30tk
voltaren akti õhukese polümeerikattega tablett
glaxosmithkline dungarvan limited - diklofenak - õhukese polümeerikattega tablett - 12,5mg 20tk; 12,5mg 10tk
amiokordin süstelahus
krka d.d. novo mesto - amiodaroon - süstelahus - 50mg 1ml 3ml 5tk
bricanyl süste-/infusioonilahus
cenexi - terbutaliin - süste-/infusioonilahus - 0,5mg 1ml 1ml 10tk
vocabria
viiv healthcare b.v. - cabotegavir sodium, cabotegravir - hiv-nakkused - viirusevastased ravimid süsteemseks kasutamiseks - vocabria tablets are indicated in combination with rilpivirine tablets for the short-term treatment of human immunodeficiency virus type 1 (hiv-1) infection in adults who are virologically suppressed (hiv-1 rna.
rekambys
janssen-cilag international nv - rilpivirine - hiv-nakkused - viirusevastased ravimid süsteemseks kasutamiseks - rekambys is indicated, in combination with cabotegravir injection, for the treatment of human immunodeficiency virus type 1 (hiv 1) infection in adults who are virologically suppressed (hiv-1 rna < 50 copies/ml) on a stable antiretroviral regimen without present or past evidence of viral resistance to, and no prior virological failure with, agents of the nnrti and ini class.
rukobia
viiv healthcare b.v. - fostemsavir trometamol - hiv-nakkused - viirusevastased ravimid süsteemseks kasutamiseks - rukobia, in combination with other antiretrovirals, is indicated for the treatment of adults with multidrug resistant hiv-1 infection for whom it is otherwise not possible to construct a suppressive anti-viral regimen.
omep 40mg gastroresistentne kõvakapsel
lex ano uab - omeprasool - gastroresistentne kõvakapsel - 40mg 30tk